Patients’ knowledge and perspectives on wet age-related macular degeneration and its treatment

References

• FriedmanDSO’ColmainBMunozBPrevalence of age-related macular degeneration in the United StatesArch Ophthalmol2004122456457215078675
   PubMed Web of Science ®Google Scholar
• ReinDBWittenbornJSZhangXForecasting age-related macular degeneration through the year 2050Arch Ophthalmol2009127453354019365036
   PubMedGoogle Scholar
• US Census BureauPopulation DivisionNational Population Projections, Summary Tables: (NP-T4) Projections of the total resident population by 5-year age groups, race, and Hispanic origin with special age categories: middle series, 1999 to 2100Washington, DCU Census Bureau2000
   Google Scholar
• RosenfeldPJBrownDMHeierJSRanimizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
   PubMed Web of Science ®Google Scholar
• BrownDMKaiserPKMichelsMRanimizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med2006355141432144417021319
   PubMed Web of Science ®Google Scholar
• AveryRLPieramiciDJRabenaMDIntravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationOphthalmology2006113336337216458968
   PubMed Web of Science ®Google Scholar
• SpaideRFLaudKFineHFIntravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degenerationRetina2006264388390
   Web of Science ®Google Scholar
• BashshurZFBazarbachiASchakalAIntravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degenerationAm J Ophthalmol200614211916815245
   PubMed Web of Science ®Google Scholar
• MangioneCMLeePPGutierrezPRDevelopment of the 25-item National Eye Institute Visual Function QuestionnaireArch Ophthalmol200111971050105811448327
   PubMed Web of Science ®Google Scholar
• ClemonsTEChewEYBresslerSBNational Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10Arch Ophthalmol2003121221121712583787
   PubMedGoogle Scholar
• KleinRKleinBELintonKLPrevalence of age-related maculopathy. The Beaver Dam Eye StudyOphthalmology19929969339431630784
   PubMed Web of Science ®Google Scholar
• ClemonsTEMiltonRCKleinRRisk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): Report No. 19Ophthalmology2005112453353915808240
   PubMed Web of Science ®Google Scholar
• Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study GroupArch Ophthalmol199211012170117081281403
   PubMedGoogle Scholar
• MitchellPWangJJForanSFive-year incidence of age-related maculopathy lesions: The Blue Mountain Eye StudyOphthalmology200210961092109712045049
   PubMed Web of Science ®Google Scholar
• TanJSMitchellPKifleyASmoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye StudyArch Ophthalmol200712581089109517698756
   PubMedGoogle Scholar
• ThorntonJEdwardsRMitchellPSmoking and age-related macular degeneration: A review of associationEye (Lond)200519993594416151432
   PubMed Web of Science ®Google Scholar
• DeAngelisMMJiFKimIKCigarette smoking, CH, APOE, ELOVL4, and risk of neovascular age-related macular degenerationArch Ophthalmol20071251495417210851
   PubMedGoogle Scholar
• SeddonJMGeorgeSRosnerBCigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular DegenerationArch Ophthalmol20061247995100116832023
   PubMedGoogle Scholar
• KlaverCCWolfsRCAssinkJJGenetic risk of age-related maculopathy. Population-based familial aggregation studyArch Ophthalmol199811612164616519869796
   PubMedGoogle Scholar
• KleinBEKleinRLeeKERisk of incident age-related eye disease in people with an affected sibling: The Beaver Dam Eye StudyAm J Epidemiol2001154320721111479184
   PubMed Web of Science ®Google Scholar
• SeddonJMAjaniUAMitchellBDFamilial aggregation of age-related maculopathyAm J Ophthalmol199712361992069186125
   PubMed Web of Science ®Google Scholar
• SchaumbergDAHankinsonSEGuoQA prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factorsArch Ophthalmol20071251556217210852
   PubMedGoogle Scholar
• SanGiovanniJPChewEYClemonsTEAge-Related Eye Disease Study Research GroupThe relationship of dietary lipid intake and age-related macular degeneration in a case-control study. AREDS Report No. 20Arch Ophthalmol2007125567167917502507
   PubMedGoogle Scholar
• Age-Related Eye Disease Study Research GroupSanGiovanniJPChewEYClemonsTEThe relationship of dietary carotenoids with age-related macular degeneration in a case-control study. AREDS Report No. 22Arch Ophthalmol200712591225123217846363
   PubMedGoogle Scholar
• HymanLSchachatAPHeQHypertension, cardiovascular disease, and age-related macular degeneration. Age-related Macular Degeneration Risk Factors Study GroupArch Ophthalmol2000117335135810721957
   PubMedGoogle Scholar
• van LeeuwenRIkramMKVingerlingJRBlood pressure, atherosclerosis, and the incidence of age-related maculopathy: The Rotterdam StudyInvest Ophthalmol Vis Sci20034493771377712939290
   PubMed Web of Science ®Google Scholar
• KleinRKleinBETommySEThe association of cardiovascular disease with the long-term incidence of age-related maculopathy: The Beaver Dam Eye StudyOphthalmology200311061273128012799274
   PubMedGoogle Scholar
• WrightSYellandMHeathcoteKFear of needles – nature and prevalence in general practiceAustralian Family Physician200938317217619283260
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research GroupA randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No.8Arch Ophthalmol2001119101417143611594942
   PubMed Web of Science ®Google Scholar
• CharkoudianLDGowerEWSolomonSDVitamin usage patterns in the prevention of age-related macular degenerationOphthalmology200811561032103818096234
   PubMed Web of Science ®Google Scholar
• KleinBEKnudtsonMDLeeKESupplements and age-related eye conditions: the Beaver Dam StudyOphthalmology200811571203120817997484
   PubMed Web of Science ®Google Scholar
• ChangCWChuGHinzBJCurrent use of dietary supplementation in patients with age-related macular degenerationCan J Ophthalmol2003381273212608514
   PubMed Web of Science ®Google Scholar
• NgWTGogginMAwareness of and compliance with recommended dietary supplement among age-related macular degeneration patientsClin Experiment Ophthlmol2006341914
   PubMed Web of Science ®Google Scholar
• van LeeuwenRKlaverCCVingerlingJRCholesterol and age-related macular degeneration: is there a link?Am J Ophthalmol2004137475075215059717
   PubMed Web of Science ®Google Scholar
• TomanySCWangJJvan LeeuwenRRisk factors for incident age-related macular degneration: pooled findings from three continentsOphthalmology200411171280128715234127
   PubMed Web of Science ®Google Scholar
• FuAZQiuYRadicanLImpact of fear of insulin or fear of injection on treatment outcomes of patients with diabetesCurr Med Res Opin20092561413142019422281
   PubMed Web of Science ®Google Scholar
• CrockettMKeystoneJ“I hate needles” and other factors impacting on travel vaccine uptakeJ Travel Med200512 Suppl 1S41S4616225805
   PubMed Web of Science ®Google Scholar
• Dahlin-IvanoffSKleppKISjostrandJDevelopment of a health education programme for elderly with age-related macular degenerationPatient Educ Counse19983416373
   PubMed Web of Science ®Google Scholar
• OwsleyCMcGwinGScilleyKFocus groups with persons who have age-related macular degeneration: Emotional issuesRehabil Psychol20065112329
   Web of Science ®Google Scholar
• MichelsSRosenfeldPJTreatment of neovascular age-related macular degeneration with ranibizumab/Lucentis®Klin Monatsbl Augenheilkd2005222648048415973626
   PubMed Web of Science ®Google Scholar
• MitchellPKorobelnikJFLanzettaPRanibizumab (Lucentis) in neovascular age-related macular degeneration: Evidence from clinical trialsBr J Ophthalmol201092121319443462
   PubMed Web of Science ®Google Scholar